Background

Science in Action.

We are a 501(c)3 transforming how infection-associated chronic conditions like LongCovid, ME/CFS & LongLyme Disease are studied, diagnosed and treated.

DONATE

Who we are

About Us

Infection-associated chronic conditions like LongCovid and ME/CFS are not mysterious or hopeless. The opposite is true: we can use new tools to study pathogen activity, environmental exposures, microbiome imbalances, neuroinflammation, gene changes, and other issues in patients with such conditions. PolyBio brings together some of the brightest minds in science to research these topics in a proactive and open-minded fashion.

Our Mission

Our vision

  • To take current research, identify important existing trends, and translate the data into information that doctors can use in the clinic to help their patients. This includes the development of new advanced testing methods that can reliably characterise a growing number of disease-related abnormalities.
  • To take current research, identify gaps where data is lacking, and use such knowledge to support and collaborate with research teams whose existing tools can tackle the problem and develop new solutions.

LongCovid

Research Consortium

 

The LongCovid Research Consortium is a scientific collaboration to rapidly and comprehensively study LongCovid. The program includes scientists and clinicians from institutions including Harvard Medical School, Stanford University, the J. Craig Venter Institute, University of Pennsylvania, the Icahn School of Medicine at Mount Sinai and Yale University.

Our Values

  • Quality

    We don’t cut corners. One high-quality study to identify and solve a problem is better than 100 studies that use sub-par technologies.

  • Urgency

    We are living in the midst of an epidemic in which the incidence of nearly every of chronic disease is on the rise. We act accordingly.

  • Innovation

    We use novel approaches and new applications of innovative technologies to build on cross-discipline expertise.

  • Compassion

    We know the tremendous suffering experienced by patients with complex chronic disease. Alleviating this suffering is our primary motivation.

  • Transparency

    We are determined to improve patient health but don’t guarantee a magic pill. We are realistic about the complexity of human biology and won’t overpromise.

Background

Areas of study

null
null

Genes

null
null

Microbiome

null
null

Pathogens

null
null

Inflammation

null
null

Brain

null
null

Immunity

null
null

Metabolism

null
null

Hormones

null
null

Gut-brain axis

Founders

Instructor, Division of Neurotherapeutics/Neuroimmunologist and expert in persistent central nervous system consequences

Microbiologist with expertise on the molecular mechanisms by which pathogens modulate human gene expression, metabolism and immunity. Also serves as PolyBio’s Research Team Coordinator.

Scientific Advisory Board

Physician at Spaulding Rehabilitation Hospital/Dean Center for Tickborne Illness and Pediatric Infectious Disease/Massachusetts General Hospital. Passionate about translating research on Borrelia burgdorferi and related tick-borne pathogens into cutting-edge clinical care.

Clinician-scientist determined to map inflammatory signatures specific to the microbiome in a creative fashion. Also an oral surgeon, Professor of Genomic Medicine, and member of the J. Craig Venter Institute infectious disease department. Life prior to disease is his mantra!

Instructor in the Neurology Department of Massachusetts General Hospital & Harvard Medical School. Innovator of experimental models for the study of amyloid biology and infection in neurodegenerative disease.

Scientist at the Max-Planck-Institute for Biology of Ageing working to understand how cellular organelles sense and respond to intracellular pathogens. Expert in mitochondrial dynamics, parasite biology, and immunometabolism.

CRISPR-Cas system discovery specialist at Mammoth Biosciences with a passion for developing & using technologies to identify novel genes from big data. Co-founder & Head of Bioinformatics at Ancilia Therapeutics focused on bacteriophage genomics and microbiome. Also an affiliate at the Lawrence Berkeley National Lab, Joint Genome Institute.

Board of Directors

2x Olympic Gold Medalist and Captain of the USA Women’s Water Polo team. She is a dedicated leader not only to her team, but also to the sport of water polo and the growth of women in sport. This passion for growth is complimented by her entrepreneurial route with her company, 6-8 Sports, which she co-founded with fellow Olympian, Tony Azevedo. At 6-8 Sports, she focuses on business development & strategy and raising funds for the company to fulfill its mission. Maggie holds a Bachelor in Science in Science, Technology, and Society as well as a Master in Science in Management & Engineering from Stanford University.

Over 15 years of experience in the private equity and investment banking industries. He is currently a Partner at Newlight Partners, where he focuses on investments in power and infrastructure. Prior to joining Newlight he worked as Managing Director to its predecessor, the Strategic Investments Group of Soros Fund Management, as an Investment Banking Analyst for Bear Stearns, and as an Analyst for the Royal Bank of Scotland. Mark holds a Bachelor in Science and Foreign Service in International Economics from Georgetown University.

Head of Business Development at Bloom Farms, a top-selling cannabis CPG company headquartered in California. Previously he spent eight years at the proprietary trading firm DRW, where he was in charge of the firm’s natural gas volatility portfolio. As an active angel investor, Dane seeks out companies in the Consumer Packaged Goods space in emerging categories focused on ancestral health. Dane holds a BA in Economics from Tufts University.

Our Approach

Innovating neuroscience and NOT psychology. We study the brain itself, with a focus on neuroinflammation, blood vessel issues, cerebrospinal fluid flow, and potential structural problems.

Research on root cause drivers of chronic inflammatory disease. Getting to the “root cause” of illness leads to development of the most effective treatments.

Exploring new frontiers. We prioritize research that moves beyond just blood tests and towards the study of tissue, nerves, cerebrospinal fluid & autopsies.

Our Work

Your investment in PolyBio Foundation’s Research supports far reaching scientific collaboration, patient-centred advances, and hope for millions worldwide. Can you imagine a better return?